NEW YORK, Feb. 23 (GenomeWeb News) - Perlegen Sciences has won a grant from the National Cancer Institute to study DNA mutations involved in colorectal cancer, in collaboration with researchers at Johns Hopkins University, the company said today.
The grant, worth $420,000 and awarded to Perlegen in fiscal year 2004, according to an NIH database, is entitled "Comprehensive Mutational Analysis of the Cancer Genome." Perlegen scientists, led by Andrew Sparks, the company's director of association studies, plan to analyze thousands of genes in colorectal tumor samples at single-base resolution and compare them to the same genes in normal tissue from the same patients. The aim is to find tumor-specific mutations.
Perlegen will work with scientists at the